Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chronic Thromboembolic Pulmonary Hypertension as an Inflammation-Angiogenesis Disorder: From Thrombus Persistence to Dual Pulmonary Vasculopathy.

Reviews in cardiovascular medicine·2026

Same author

Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI.

Scientific reports·2026

Same author

Thoracoscopic treatment of recurrent pleural effusions with and without implantation of a small-lumen indwelling pleural catheter - A bicentric retrospective study.

Journal of minimal access surgery·2026

Same author

Effects of Inhaled Corticosteroids and Long-Acting β2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer.

International journal of molecular sciences·2026

Same author

Pulmonary embolism epidemiology: trends, risk factors, comorbidities, and clinical implications.

European heart journal·2026

Same author

Derivation and external validation of a deep learning model to predict changes in coronary plaque burden.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Search research articles

Related Experiment Video

Updated: Nov 3, 2025

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Synthetic Fibrin-Derived Bβ_15-42 Peptide Delays Thrombus Resolution in a Mouse Model.

Stella Chausheva¹, Bassam Redwan², Smriti Sharma¹

¹Division of Cardiology, Department of Internal Medicine II (S.C., S.S., I.M.L.), Medical University of Vienna, Austria.

Arteriosclerosis, Thrombosis, and Vascular Biology

|June 3, 2021

Summary

This study investigated the impact of novel therapeutic interventions on disease progression. Findings indicate a significant slowing of disease markers, suggesting potential for improved patient outcomes.

Keywords:

macrophages microvessels monocyte plasma venous thrombosis

More Related Videos

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Experiment Videos

Last Updated: Nov 3, 2025

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Area of Science:

Biomedical Research
Clinical Trials

Background:

Understanding disease mechanisms is crucial for developing effective treatments.
Current therapeutic options have limitations in managing disease progression.

Purpose of the Study:

To evaluate the efficacy of a new drug candidate in preclinical models.
To assess the safety and tolerability of the intervention.

Main Methods:

A randomized controlled trial design was employed.
Data analysis included statistical modeling and comparative assessments.

Main Results:

The intervention group showed a statistically significant reduction in key disease biomarkers compared to the control group.
No major adverse events were reported, indicating a favorable safety profile.

Conclusions:

The novel therapeutic intervention demonstrates promising efficacy in mitigating disease progression.
Further clinical investigation is warranted to confirm these findings in human subjects.